Tracheal Collapse--Dogs
BASICS
DEFINITION
• Tracheal collapse is a condition characterized by a dynamic reduction in the luminal diameter of the large, conducting airway as a result of weakening of cartilaginous support of the trachea. Redundancy of the dorsal tracheal membrane may further compromise the width of the lumen and compound the clinical signs. Compression of the trachea or bronchi as a result of hilar lymphadenopathy, left atrial enlargement, or external masses is not considered part of the condition described here.
Pathophysiology
• Tracheal cartilages from dogs with tracheal collapse have been shown to be hypocellular.
• Lack of chondroitin sulfate and/or decreased glycoproteins within the cartilage matrix results in a reduction in bound water and loss of turgidity in the cartilage.
• Abnormalities in the cartilage structure may represent degenerative changes secondary to long-standing small airway disease, or they may result from defects of chondrogenesis associated with primary genetic or nutritional abnormalities.
• Abnormal pressure gradients develop along the trachea during respiration, which lead to dynamic collapse of the airway.
• The weakened cartilage allows flattening of the tracheal ring structure, and the trachea collapses, typically in a dorsoventral direction.
• Increased tension on the trachealis dorsalis muscle or neurogenic atrophy of the muscle causes stretching of the dorsal tracheal membrane with protrusion into the airway lumen.
• Chronic pressure fluctuations within the airway lead to perpetuation of small airway disease and more widespread pulmonary dysfunction.
• Mechanical trauma to the tracheal mucosa from collapse of the dorsal tracheal membrane during coughing exacerbates airway edema and inflammation and may lead to pseudomembrane formation.
Systems Affected
• Respiratory--signs from upper airway disorders, such as everted saccules, laryngeal paralysis, and elongated soft palate, may be worsened by severe or protracted dyspnea; lower respiratory tract infection or inflammation are more likely a result of poor tracheal clearance of secretions and bacteria
• Cardiovascular--if the combination of pulmonary diseases is severe enough to lead to pulmonary hypertension
• Nervous--when syncope develops from hypoxia or a vasovagal reflex associated with cough
Genetics Unknown
Incidence Prevalence
Unknown, although the disorder is commonly diagnosed clinically
Geographic Distribution Worldwide
SIGNALMENT
Species Primarily dogs, rarely cats
Breed Predilections
Miniature poodle, Yorkshire terrier, chihuahua, Pomeranian, other small and toy breeds
Mean Age and Range
Middle-aged to elderly with onset of signs from 4-14 years of age. A congenital form also may be observed.
Predominant Sex N/A
SIGNS
General Comments
Clinical signs usually are worsened by excitement, heat, humidity, exercise, or obesity.
Historical Findings
• A dry "honking" cough is classically described for tracheal collapse.
• A chronic history of intermittent coughing or difficulty breathing may be reported.
• Retching is often noted, resulting from an attempt to clear the larynx of pulmonary secretions.
• Tachypnea, exercise intolerance, and/or respiratory distress commonly are reported.
• Cyanosis or syncope may be found in severely affected individuals.
Physical Examination Findings
• Tracheal sounds may be wheezing or musical.
• Enhanced tracheal sensitivity generally is present.
• An end-expiratory snap may be heard when large segments of the airway collapse on forceful expiration.
• Cervical tracheal collapse is present with inspiratory dyspnea, while intrathoracic collapse may be associated with expiratory dyspnea.
• Wheezes or crackles indicate the presence of small airway disease.
• Mitral insufficiency murmurs often are found as a result of the commonality of both cardiac and respiratory disease in small-breed dogs.
• The heart rate generally is normal or decreased for the breed of dog.
• A pronounced second heart sound is suggestive of elevated pulmonary arterial pressures.
• Hepatomegaly has been reported (etiology unknown).
CAUSES
• Congenital/nutritional/familial defects or failures of chondrogenesis
• Chronic small airway disease
RISK FACTORS
• Pulmonary infection
• Upper airway obstruction
DIAGNOSIS
DIFFERENTIAL DIAGNOSIS
• Chronic bronchitis
• Congestive heart failure
• Laryngeal paralysis
• Laryngeal mass
• Pneumonia--viral, bacterial, fungal, allergic, or parasitic
• Intratracheal mass or foreign body
• Cervical or mediastinal mass
• Infectious tracheobronchitis
• Bronchiectasis
CBC/BIOCHEMISTRY/URINALYSIS
• Minimum data base to assess general health
• CBC--inflammatory leukogram (secondary to chronic stress of low-grade pneumonia); polycythemia may be found when chronic obstructive pulmonary disease is present
OTHER LABORATORY TESTS
• Arterial blood gases can be used to assess the degree of respiratory dysfunction.
• Calculating the alveolar-arterial oxygen difference (DA-a O2) from blood gas data will differentiate the pulmonary contribution to hypoxemia from that associated with upper airway obstruction.
• DA-a O2 = PAO2 - PaO2 where PAO2 = 0.21 x (PB - PH2O) - PaCO2/0.8 (normal < 15; PB = barometric pressure; PH2O = water vapor pressure [47 at 37o C] and PaCO2 from blood gas data)
IMAGING
Radiography
• Tracheal collapse can be identified by radiography in the majority (60%) of patients.
• Inspiratory films will show cervical tracheal collapse.
• Expiratory films are useful for outlining intrathoracic tracheal collapse. Collapse of the mainstem bronchus and ballooning of the cervical trachea also may be seen.
• Bronchitis, pneumonia, and bronchiectasis may be identified.
• Right-sided heart enlargement may be found secondary to chronic pulmonary disease. Breed conformation may confound interpretation of the cardiac silhouette.
Fluoroscopy
Dynamic collapse of the trachea and/or dorsal tracheal membrane may be more easily identified after induction of cough.
OTHER DIAGNOSTIC PROCEDURES
Bronchoscopy
• The severity of tracheal collapse can be graded (1-4) and small airway disease identified.
• Grade 1--almost normal, slightly pendulous trachealis muscle
• Grade 2--reduction of the tracheal lumen by 50%
• Grade 3--reduction of the tracheal lumen by 75% with the trachealis muscle almost brushing the tracheal cartilage
• Grade 4--tracheal cartilages are flattened, < 10% of the lumen may be visible, a double lumen may be seen when the trachealis muscle contacts the ventral surface of the trachea
• Samples should be submitted for bacterial culture/sensitivity and cytology to guide therapy.
GROSS AND HISTOPATHOLOGIC FINDINGS
• The trachealis muscle is greatly elongated and the cartilages are flattened.
• Tracheal inflammation or pseudomembrane formation may be evident.
• Hypocellularity of the cartilage with decreased glycoproteins and chondroitin sulfate is noted microscopically.
• Variable changes associated with chronic obstructive pulmonary disease may be noted.
TREATMENT
INPATIENT VERSUS OUTPATIENT
• Stable patients can be discharged on appropriate therapy.
• Severly dyspneic patients may require oxygen therapy or heavy sedation.
ACTIVITY
Severely limited pending stabilization
DIET
The majority of affected dogs will improve by achieving weight loss.
CLIENT EDUCATION
• Obesity, overexcitement, and humid conditions can cause a crisis.
• Harnesses should be used in place of collars.
SURGICAL CONSIDERATIONS
Early intervention in selected cases (primarily cervical tracheal collapse) by a skilled surgeon may improve quality of life when adequate stablization of the airway can be achieved and when chronic pulmonary changes do not limit resolution of disease.
MEDICATIONS
DRUGS AND FLUIDS
• Sedation and cough suppression may be achieved with butorphanol (0.05 mg/kg IV, SC q6h).
• The addition of acepromazine (0.025 mg/kg SC) may enhance sedative effects.
• Narcotic cough suppressants such as butorphanol (0.5-1.0 mg/kg PO q6h-q12h) or hydrocodone (0.22 mg/kg PO q6h-q12h) are effective for chronic therapy.
• Some dogs may respond to Choledyl elixir (1 cc/4.5 kg q8h) despite inadequate theophylline levels.
• Theo-dur sustained release tablets (20 mg/kg q12h) or Slo-bid (25 mg/kg) are recommended to dilate the smaller airways and decrease pressure gradients along the trachea.
• Prednisone (0.5-1.0 mg/kg q12h tapered to q48h) may aid in reducing tracheal or bronchial inflammation.
CONTRAINDICATIONS
None
PRECAUTIONS
• Theo-dur tablets should be used, not sprinkles or capsules.
• Generic slow-release theophylline products should not be substituted because of erratic pharmacokinetics.
• Long-term steroid use should be avoided because of the propensity for weight gain or diseases associated with steroid excess.
POSSIBLE INTERACTIONS
• Primarily with theophylline
• Theophylline metabolism is increased by concurrent treatment with ketoconazole and phenobarbital. Inadequate plasma levels result.
• Metabolism is decreased by flouroquinolones (Baytril), erythromycin, cimetidine, beta blockers, steroids, mexiletine, and thiabendazole. Toxic plasma levels results, causing gastrointestinal upset, nervousness, or tachycardia.
• Changes in drug pharmacokinetics associated with congestive heart failure, cor pulmonale, and liver disease necessitate a reduction in dosage.
ALTERNATE DRUGS
Robitussin DM has offered palliation in some patients.
FOLLOW-UP
PATIENT MONITORING
• Exercise tolerance
• Arterial blood gases
PREVENTION/AVOIDANCE
• Avoid obesity in breeds commonly afflicted.
• Avoid heat and humidity.
POSSIBLE COMPLICATIONS
Intractable dyspnea leading to respiratory failure.
EXPECTED COURSE AND PROGNOSIS
• Prognosis may be based on bronchoscopic evidence of airway obstruction.
• Various combinations of medical therapy, in conjunction with weight control, should be tried to provide palliation.
• Surgery may benefit some patients, primarily those with cervical tracheal collapse.
MISCELLANEOUS
ASSOCIATED CONDITIONS
• Chronic bronchitis
• Laryngeal paralysis
• Everted laryngeal saccules
• Pulmonary hypertension
• Affected breeds commonly are afflicted with mitral insufficiency, which can complicate the diagnosis.
AGE RELATED FACTORS N/A
ZOONOTIC POTENTIAL N/A
PREGNANCY N/A
SYNONYMS N/A
SEE ALSO
Bronchitis, Chronic (COPD)
ABBREVIATIONS
DAaO2 = alveolar-arterial oxygen difference
PAO2 = alveolar oxygen
PaO2 = arterial oxygen
PB = barometric pressure
PH2O = water vapor pressure
PaCO2 = arterial carbon dioxide
References
Hedlund CS. Tracheal collapse. Prob Vet Med 1991;3:229.
Done SH, Drew RA. Observations on the pathology of tracheal collapse in dogs. J Small Anim Pract 1976;17:783.
White RAS, Williams JM. Tracheal collapse--is there really a role for surgery? A survey of 100 cases. J Small Animal Pract 1994;35:191-196.
Tangner CH, Hobson HP. A retrospective study of 20 surgically managed cases of collapsed trachea. Vet Surg 1982;11:146-149.
McKiernan BC. Current uses and hazards of bronchodilator therapy. In: Kirk RW, Bonagura JD, eds. Current veterinary therapy XI, small animal practice. Philadelphia: WB Saunders, 1992:660-668.
Author Lynelle Johnson
Consulting Editors Lynelle Johnson and Bradley L. Moses